- Home
- ARGX vs AXON Comparison
ARGX vs AXON Comparison
Compare ARGX & AXON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- AXON
- Stock Information
- Founded
- ARGX 2008
- AXON 1993
- Country
- ARGX Netherlands
- AXON United States
- Employees
- ARGX N/A
- AXON N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- AXON Ordnance And Accessories
- Sector
- ARGX Health Care
- AXON Industrials
- Exchange
- ARGX Nasdaq
- AXON Nasdaq
- Market Cap
- ARGX 35.2B
- AXON 29.8B
- IPO Year
- ARGX 2017
- AXON N/A
- Fundamental
- Price
- ARGX $590.80
- AXON $637.48
- Analyst Decision
- ARGX Strong Buy
- AXON Strong Buy
- Analyst Count
- ARGX 21
- AXON 13
- Target Price
- ARGX $619.79
- AXON $434.54
- AVG Volume (30 Days)
- ARGX 302.1K
- AXON 878.6K
- Earning Date
- ARGX 10-31-2024
- AXON 11-07-2024
- Dividend Yield
- ARGX N/A
- AXON N/A
- EPS Growth
- ARGX N/A
- AXON 94.20
- EPS
- ARGX N/A
- AXON 3.85
- Revenue
- ARGX $1,908,659,000.00
- AXON $1,940,449,000.00
- Revenue This Year
- ARGX $61.99
- AXON $33.11
- Revenue Next Year
- ARGX $42.48
- AXON $22.20
- P/E Ratio
- ARGX N/A
- AXON $158.30
- Revenue Growth
- ARGX 85.56
- AXON 32.32
- 52 Week Low
- ARGX $327.73
- AXON $224.28
- 52 Week High
- ARGX $611.22
- AXON $624.84
- Technical
- Relative Strength Index (RSI)
- ARGX 56.12
- AXON 82.86
- Support Level
- ARGX $558.15
- AXON $592.00
- Resistance Level
- ARGX $592.29
- AXON $618.07
- Average True Range (ATR)
- ARGX 12.42
- AXON 21.19
- MACD
- ARGX -2.11
- AXON 7.15
- Stochastic Oscillator
- ARGX 56.76
- AXON 97.26
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About AXON Axon Enterprise Inc.
Axon Enterprise Inc develops, manufactures, and sells conducted energy devices and cloud-based digital evidence management software designed for use by law enforcement, corrections, military forces, private security personnel, and private individuals for personal defense. The company operates in two segments: Taser and software & sensors. Taser develops and sells CEDs used for protecting users and virtual reality training. Software and sensors manufacture fully integrated hardware and cloud-based software solutions such as body cameras, automated license plate reading, and digital evidence management systems. Axon delivers its products worldwide and derives the majority of its revenue from the software & sensors segment and geographically from the United States.